Skip to main content
. 2018 Jun 19;7(2):287–306. doi: 10.1007/s40120-018-0102-3

Table 2.

Study design and participant demographics

Study (first author) No. of subjects Age, years
Mean (SD)
Gender
% Female
Education, years
Mean (SD)
% Type MS (RR/SP/PP/PR/CIS) Disease duration
Mean (SD)
EDDS
Mean (SD)
SDMT CVLT-II BVMT-R
Costers [40]
 MS 97 45.42 (9.24) 70% 14.28 (1.86) 84/12/4/0/0 12.97 (7.16) 3.50 (2.50) 52.1 (13.1) 60.1 (12.9) 25.4 (29)
 HC 97 43.52 (12.69) 77% 14.69 (1.61) 61 (10.2) 61.3 (60) 28.2 (5.1)
Dusankova [36]
 MS 369 34 (10) 68% 14 [3] 68/26/3/3/0 8 (7) 3 (1.5) 50 (13) 60 (8) 23 (7)
 HC 134 34 (9) 71% 14 (2.5) 65 (9) 52 (11) 29 (4)
Eshaghi [41]
 MS 156 34.05 (9.09) 71% 14.13 (2.97) 80/20/0/0/0 6.07 (5.08) 2.5a (7.5)a 43.93 (16.55) 49.23 (10.39) 20.88 (7.65)
 HC 90 33.65 (9.48) 63% 14.27 (3.56) 55.58 (16.48) 55.31 (8.46) 25.01 (7.38)
Giedraitienė [42]
 MS 50 38.8 (10.2) 32% 15.9 (2.8) 88/6/2/0/4 11.7 (9.2) 3.3 (1.3) 42.7 (13.9) 55.9 (10) 23.1 (7)
 HC 20 36.7 (16.4) 10% 17.5 (3.5) 57.7 (11.5) 65.7 (5.9) 29.6 (4.1)
Goretti [43]
 MS
 HC 23 and 243 38.9 (13) and 38.2 (13.1)

66%

65%

14.9 (3) 56.3 (11.3)

56.3

(9)

27.9 (6.1)
Niccolai [44]
 MS 192 41.4 (10.8) 74% 12.3 (3.5) 100/0/0/0/0

12.7

(1.7)

2.7

(1.7)

46.4 (12.8) 49.9 (12.1)

23.7

(8)

 HC 200 56.3 (11.3)

56.3

(9)

27.9 (6.1)
Niino [45]
 MS 156 41.4 (9.3) 69% 14.1 (1.9) 88/11/1/0/0

2.4

(2.0)

47.9 (14) 48.6 (12.6) 23.5 (8.4)
 HC 126 39.3 (11.9) 72% 14.3 (1.6)

61

(9.5)

55.7 (10.5) 28.3 (5.4)
O’Connell [46]
 MS 67 43.9 (12.1) 73%

13.6

(2.7)

70/28/2/0/0

10.2

(8.4)

1.8

(0.9)

46 (12.9) 45.3 (10.2) 17.9 (7.1)
 HC 66 42.7 (12.8) 68%

14.1

(3.1)

56.1 (10.6) 53.6 (9.1) 20.9 (6.5)
Ozakbas [47]
 MS 173 37.5 (10.7) 71%

13.9

(7.3)

151/18/4/0/0

9.2

6.1)

2.4

(1.7)

43.2 (12.5) 45.7 (11.3) 16.9 (8.5)
 HC 153 36.9 (8.9) 71%

15.4

(8.8)

53.5 (9.5) 53.9 (7.7) 22.5 (9.2)
Polychroniadou [48]
 MS 44 40.2 (9.9) 61%

14.1

(4.8)

77/12/9/0/2 RR 9.6 (3.7); SP 7.5 (3.7); PP 6.0 (2.6); CIS 1.6 (0.5) 45 (17.2) 55.5 (12.3) 18.5 (8.3)
 HC 79 36.2 (10.6) 61%

15.4

(5.5)

61.4 (13.1) 60.5 (10.7) 22.1 (6.5)
Sandi [49]
 MS 65 41.9 (8.9) 75%

n = 31  < 12 years;

n = 34 ≥ 13 years

100/0/0/0/0

11.1

(7.6)

2.5

(1.8)

55.62 (15.48) 55.37 (10.71) 22.54 (8.54)
 HC 65 40.9 (11.8) 75%

n = 31 < 12 years;

n = 34 ≥ 13 years

66.82 (12.44) 59.03 (8.29) 26.68 (5.56)
Spedo [50]
 MS 58 41.2 (12.2) 69% 12.7 (5.2) 100/0/0/0/0

8.3

(6.6)

2.2

(2)

35.9 (16.1) 42.1 (12.4) 19.9 (8.6)
 HC 58 40.3 (11.9) 55% 12.5 (3.6) 47 (13) 53.4 (10.8) 23.8 (7.7)
Strober [10]
 MS 65

45

(9.9)

80% 14 (2.4) 72/22/3/1.5/1.5

10.2

(7.6)

3.3

(1.7) (n = 54)

48.4 (10.1) 48.1 (9.8) 26.2 (5.8)
 HC 46 45.2 (9.9) 85%

15

(1.8)

62.1 (10.7) 56.7 (8.1) 21.1 (6.4)
Vanotti [51]
 MS 50 43.42 (10.17) 74% 14.86 (2.78) 78/18/4/0/0 13.06 (9.08) 3.29 (2.55) 45.14 (16.07) 50.92 (12.37) 20.7 (7.74)
 HC
Vanotti [52]
 MS 50 43.42 (10.17) 74%

14.86

(2.78)

78/18/4/0/0 13.06 (9.08) 3.29 (2.55) 45.14 (16.07) 50.92 (12.37) 20.7 (7.74)
 HC 100 42.37 (10.07) 75%

14.94

(2.49)

56.71 (10.85) 60.88 (10.46) 23.44 (5.84)
Walker [53]
 MS 57 45.44 (9.93) 72%

15.44

(2.68)

77/16/7/0/0 10.11 (7.72) 2.70 (1.85) 49.65 (10.78) 51.63 (10.05) 24.6 (6.54)
 HC 51 41.92 (10.78) 86%

16.31

(2.11)

59.11 (8.46) 57.72 (7.97) 29.8 (3.63)

aMedian and (range)